Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial (2020)
Presentation / Conference
Rifkin-Zybutz, R., Macneill, S., Dickens, C., Campbell, J., Chew-Graham, C., Peters, T., …Kessler, D. (2020, July). Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial. Poster presented at 28th European Congress of Psychiatry, Madrid, Spain

Introduction: Mirtazapine has been shown to be effective in treating patients with both depression and anxiety symptoms.1 This has not been examined in primary care. Objectives: We examined whether anxiety moderated the effect of mirtazapine com... Read More about Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial.

EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE (2020)
Presentation / Conference
Hawarden, A. W., Paskins, Z., Ediriweera Desilva, E., Herron, D., Machin, A., Jinks, C., …Chew-Graham, C. (2020, April). EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE. Poster presented at British Society for Rheumatology Annual Conference 2020, Glasgow, Scotland, UK

Background The INCLUDE (INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community) pilot trial aimed to evaluate the feasibility and acceptability of a nurse-delivered review in primary care for people... Read More about EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE.